Windtree Therapeutics has announced strategic plans to raise up to $520 million dedicated to expanding its BNB holdings and diversifying its corporate treasury. The pharmaceutical firm will utilize an equity line of credit (ELOC) and stock purchase agreement to secure the funding, while partnering with cryptocurrency exchange Kraken for end-to-end treasury management of its digital assets.
Kraken will integrate custody, trading, and over-the-counter services to optimize BNB liquidity control and operational efficiency for Windtree’s crypto assets. This institutional collaboration reflects confidence in BNB’s long-term value proposition. BNB has surged 17.5% in valuation over the past month, recently hitting a record high before undergoing a modest correction. As of the latest data, BNB trades at $759, marking a marginal 1.68% daily downturn.